Evidence of Fraudulent Claims by Hologic/Gen-Probe in relation to Daniel Densham’s IP Portfolio brings Pacbio Deal into focus.
The fraudulently claimed IP portfolio of Daniel Densham, Managing Director of Molecular Research Limited, appears have been Licensed to Pacific Biosciences Inc, within the questionable Pacific (gen probe)/Hologic deal.
— Molecular Research (@MoleResLtd) January 17, 2017
We understand that because of the sensitive nature of this issue, individuals may need to send information to us anonymously. You can do this by going to protonmail.com and setting up an encrypted account (no real name is, of course, required). This system is so secure that Protonmail is unable to access the actual encrypted mail.
Then send your information to firstname.lastname@example.org.
Lets not let the actions of a few immoral individuals affect the lives of employees, students, researchers and patients.
We thank you for your commitment toward the freedom of knowledge and healthcare for all.
Merry Christmas and a Happy New Year from all at Molecular Research Limited!
Molecular Research Limited